AU2024976A - Compositions comprising heparin andan ergot alkaloid - Google Patents

Compositions comprising heparin andan ergot alkaloid

Info

Publication number
AU2024976A
AU2024976A AU20249/76A AU2024976A AU2024976A AU 2024976 A AU2024976 A AU 2024976A AU 20249/76 A AU20249/76 A AU 20249/76A AU 2024976 A AU2024976 A AU 2024976A AU 2024976 A AU2024976 A AU 2024976A
Authority
AU
Australia
Prior art keywords
andan
heparin
compositions
ergot alkaloid
ergot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU20249/76A
Other versions
AU512782B2 (en
Inventor
H. and Welzel D Bohlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2554533A external-priority patent/DE2554533C3/en
Priority claimed from DE19762625403 external-priority patent/DE2625403A1/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU2024976A publication Critical patent/AU2024976A/en
Application granted granted Critical
Publication of AU512782B2 publication Critical patent/AU512782B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Electronic Switches (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AU20249/76A 1975-12-04 1976-12-03 Compositions comprising heparin andan ergot alkaloid Expired AU512782B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DEDE2554533 1975-12-04
DE2554533A DE2554533C3 (en) 1975-12-04 1975-12-04 Use of dihydroergotamine and heparin
DEDE2625403 1976-06-05
DE19762625403 DE2625403A1 (en) 1976-06-05 1976-06-05 Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone

Publications (2)

Publication Number Publication Date
AU2024976A true AU2024976A (en) 1978-06-08
AU512782B2 AU512782B2 (en) 1980-10-30

Family

ID=25769698

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20249/76A Expired AU512782B2 (en) 1975-12-04 1976-12-03 Compositions comprising heparin andan ergot alkaloid

Country Status (17)

Country Link
JP (1) JPS5270031A (en)
AU (1) AU512782B2 (en)
CS (1) CS216164B2 (en)
ES (1) ES453869A1 (en)
FR (1) FR2333513A1 (en)
GB (1) GB1557331A (en)
HK (1) HK3083A (en)
IE (1) IE44359B1 (en)
IL (1) IL51043A (en)
IT (1) IT7827782A0 (en)
MY (1) MY8400064A (en)
NL (1) NL172401C (en)
NZ (1) NZ182790A (en)
PH (1) PH12759A (en)
PT (1) PT65919B (en)
SE (1) SE441142B (en)
SG (1) SG63482G (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF
CH656533A5 (en) * 1982-12-10 1986-07-15 Sandoz Ag THERAPEUTIC PREPARATION CONTAINING HYDRATED ERGOTAL CALOIDS AND LOW MOLECULAR HEPARINE.

Also Published As

Publication number Publication date
ES453869A1 (en) 1978-01-16
IL51043A (en) 1980-02-29
SG63482G (en) 1983-09-09
NZ182790A (en) 1979-03-16
JPS5270031A (en) 1977-06-10
MY8400064A (en) 1984-12-31
SE441142B (en) 1985-09-16
IL51043A0 (en) 1977-02-28
IT7827782A0 (en) 1978-09-18
FR2333513B1 (en) 1980-03-28
NL172401B (en) 1983-04-05
PT65919B (en) 1978-07-05
FR2333513A1 (en) 1977-07-01
HK3083A (en) 1983-01-20
NL7613316A (en) 1977-06-07
IE44359B1 (en) 1981-11-04
AU512782B2 (en) 1980-10-30
NL172401C (en) 1983-09-01
PT65919A (en) 1977-01-01
IE44359L (en) 1977-06-04
CS216164B2 (en) 1982-10-29
GB1557331A (en) 1979-12-05
PH12759A (en) 1979-08-09
SE7613252L (en) 1977-06-05

Similar Documents

Publication Publication Date Title
AU520754B2 (en) Nasal ergot alkaloid compositions
AU508628B2 (en) Ergot alkaloid compositions
AU500961B2 (en) Squelch circuit
AU514288B2 (en) Ergoline derivatives
AU511507B2 (en) Funcationalised adenine derivatives
AU3281078A (en) Ergot derivatives
AU534051B2 (en) Ergot alkaloid slow-release compositions
PH12202A (en) Ergot derivative
AU512782B2 (en) Compositions comprising heparin andan ergot alkaloid
GB1485738A (en) Ergot alkaloids
AU6302180A (en) Ergot alkaloid
AU506218B2 (en) Ergot alkaloids
AU5923380A (en) Ergot alkaloid
AU520738B2 (en) 8-ureidomethyl ergoline derivatives
HK81085A (en) Pharmaceutical compositions containing an ergot alkaloid and heparin
AU525818B2 (en) Ergot peptide alkaloid derivates
AU502091B2 (en) Urea-formaldehyde compositions
AU520880B2 (en) Ergoline derivatives
PT65756B (en) Alkaloid derivative
AU502928B2 (en) 8-cyanoethyl ergolines
AU2103877A (en) Ergot alkaloid derivatives
AU513467B2 (en) Antihypertensive composition
AU496252B2 (en) Bearing mounting
AU513774B2 (en) Ergoline derivatives
AU495082B2 (en) 7-(alpha-uredoacylamido)-methoxycephalosporins